Treatment of relapsed Wilms tumour (WT) patients: Experience with topotecan. A report from the SIOP Renal Tumour Study Group (RTSG)-Reference-Cited by-同舟云学术

Treatment of relapsed Wilms tumour (WT) patients: Experience with topotecan. A report from the SIOP Renal Tumour Study Group (RTSG)

Published:2014-12-29 Issue:4 Volume:62 Page:598-602
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Mavinkurve-Groothuis A. M. C.¹²,van den Heuvel-Eibrink M. M.²³,Tytgat G. A.²⁴,van Tinteren H.⁵,Vujanic G.⁶,Pritchard-Jones K. L. P.⁷,Howell L.⁸,Graf N.⁹,Bergeron C.¹⁰,Acha T.¹¹,Catania S.¹²,Spreafico F.¹²

Affiliation:

1. Department of Pediatric Hematology and Oncology; University Medical Center Utrecht; Wilhelmina Children's Hospital Utrecht The Netherlands

2. Princes Maxima Center for Pediatric Oncology; Utrecht; The Netherlands

3. Department of Pediatric Hematology and Oncology; Erasmus MC; Sophia Children's Hospital Rotterdam The Netherlands

4. Department of Pediatric Oncology; Emma Children's Hospital; Academic Medical Centre Amsterdam The Netherlands

5. Department of Statistics; Dutch Cancer Institute (NKI-AvL); Amsterdam The Netherlands

6. Department of Pathology; Cardiff University School of Medicine; Heath Park Cardiff United Kingdom

7. Institute of Child Health; University College London; London United Kingdom

8. Alder Hey Children's NHS Foundation Trust; Liverpool; United Kingdom

9. Saarland University; Department of Pediatric Oncology & Hematology; Homburg Germany

10. Institut d'Hématologie et d'Oncologie Pédiatrie; Lyon; France

11. Department of Pediatric Oncology; Hospital Materno-Infantil; Malaga Spain

12. Pediatric Oncology Unit; Department of Hematology and Pediatric Oncology; Fondazione IRCCS Istituto Nazionale dei Tumori; Milan Italy

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.25357/fullpdf

Reference30 articles.

1. Outcome of patients with Stage II/favorable histology Wilms tumor with and without local tumor AT a report from the National Wilms Tumor Study Group;Green;Pediatr Blood Cancer,2014

2. Prognostic factors in nonmetastatic, favorable histology Wilms' tumor. Results of the Third National Wilms' Tumor Study;Breslow;Cancer,1991

3. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms' tumor: A report from the National Wilms' Tumor Study Group;Green;J Clin Oncol,1998

4. SIOP. Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): A randomised controlled trial;de Kraker;Lancet,2004

5. Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01;Graf;Eur J Cancer,2012

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bilateral Wilms tumor: 10-year experience from a single center in China;Translational Cancer Research;2024-02

2. Bioinformatics analysis and identification of genes and pathways involved in patients with Wilms tumor;Translational Cancer Research;2022-08

3. Childhood renal tumors: surgical treatment and results;Anatolian Current Medical Journal;2022-01-24

4. Recurrent/Relapsed Wilms’ Tumor;Wilms’ Tumor;2022

5. Identification of a ferroptosis-related lncRNA signature with prognosis for Wilms tumor;Translational Pediatrics;2021-10